Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm

Dustin Baldwin, Ahmed M. Ali, Maria S. Altieri, Eric J. DeMaria
{"title":"Marginal ulceration after Roux-en-Y gastric bypass - literature review and management algorithm","authors":"Dustin Baldwin, Ahmed M. Ali, Maria S. Altieri, Eric J. DeMaria","doi":"10.20517/mtod.2023.33","DOIUrl":null,"url":null,"abstract":"Roux-en-Y gastric bypass (RYGB)-associated marginal ulceration (MU) poses significant challenges for both patients and clinicians. Persistent symptoms such as epigastric pain, nausea, and reduced oral intake complicate the clinical landscape. MU can lead to severe complications, including anastomotic strictures, bleeding, and perforations. The etiology of MU is intricate, likely stemming from a combination of technical and patient-related factors. Technical considerations involve ischemia, tension on the anastomosis causing tissue ischemia, anastomotic technique, gastric pouch size, foreign bodies, and gastrogastric fistulas. Patient factors encompass smoking, nonsteroidal anti-inflammatory drugs (NSAIDs), Helicobacter pylori (H. pylori), and uncontrolled medical comorbidities. Diagnosis primarily relies on upper endoscopy. Initial treatment typically involves proton pump inhibitors (PPI) and sucralfate. Should these measures prove insufficient, the addition of misoprostol and the implementation of endoscopic techniques, such as oversewing or stenting across the ulcer, may be considered to facilitate healing. Ultimately, if medical and endoscopic interventions fail, surgical options become imperative. These include transthoracic truncal vagotomy and revisional procedures such as resection of the ulcer with redo gastrojejunal anastomosis, resection of the ulcer and pouch with esophagojejunal anastomosis, or resection and reversal to normal anatomy. Surgical interventions demand expertise and should be conducted at qualified, high-volume centers. To support clinicians in comprehending the nuances of MU, we conducted a literature review, presenting a summary of our findings. Additionally, we propose an algorithm delineating the escalation of treatments for MU, ranging from medical to endoscopic to surgical therapies. This concise review aims to assist clinicians in both the prevention and treatment of marginal ulceration.","PeriodicalId":91001,"journal":{"name":"Metabolism and target organ damage","volume":"333 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolism and target organ damage","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/mtod.2023.33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Roux-en-Y gastric bypass (RYGB)-associated marginal ulceration (MU) poses significant challenges for both patients and clinicians. Persistent symptoms such as epigastric pain, nausea, and reduced oral intake complicate the clinical landscape. MU can lead to severe complications, including anastomotic strictures, bleeding, and perforations. The etiology of MU is intricate, likely stemming from a combination of technical and patient-related factors. Technical considerations involve ischemia, tension on the anastomosis causing tissue ischemia, anastomotic technique, gastric pouch size, foreign bodies, and gastrogastric fistulas. Patient factors encompass smoking, nonsteroidal anti-inflammatory drugs (NSAIDs), Helicobacter pylori (H. pylori), and uncontrolled medical comorbidities. Diagnosis primarily relies on upper endoscopy. Initial treatment typically involves proton pump inhibitors (PPI) and sucralfate. Should these measures prove insufficient, the addition of misoprostol and the implementation of endoscopic techniques, such as oversewing or stenting across the ulcer, may be considered to facilitate healing. Ultimately, if medical and endoscopic interventions fail, surgical options become imperative. These include transthoracic truncal vagotomy and revisional procedures such as resection of the ulcer with redo gastrojejunal anastomosis, resection of the ulcer and pouch with esophagojejunal anastomosis, or resection and reversal to normal anatomy. Surgical interventions demand expertise and should be conducted at qualified, high-volume centers. To support clinicians in comprehending the nuances of MU, we conducted a literature review, presenting a summary of our findings. Additionally, we propose an algorithm delineating the escalation of treatments for MU, ranging from medical to endoscopic to surgical therapies. This concise review aims to assist clinicians in both the prevention and treatment of marginal ulceration.
Roux-en-Y 胃旁路术后的边缘溃疡--文献综述和处理算法
与 Roux-en-Y 胃旁路术(RYGB)相关的边缘溃疡(MU)给患者和临床医生都带来了巨大的挑战。上腹部疼痛、恶心和口腔摄入量减少等持续性症状使临床情况变得更加复杂。MU 可导致严重的并发症,包括吻合口狭窄、出血和穿孔。MU 的病因错综复杂,可能源于技术和患者相关因素的综合作用。技术因素包括缺血、造成组织缺血的吻合口张力、吻合技术、胃袋大小、异物和胃胃瘘。患者因素包括吸烟、服用非甾体类抗炎药(NSAID)、幽门螺旋杆菌(H. pylori)和未得到控制的并发症。诊断主要依靠上内镜检查。初始治疗通常包括质子泵抑制剂(PPI)和蔗糖酸盐。如果这些措施被证明效果不佳,则可考虑加用米索前列醇,并采用内窥镜技术,如在溃疡处进行缝合或支架植入,以促进溃疡愈合。最后,如果药物和内窥镜干预无效,则必须选择手术治疗。这包括经胸迷走神经切断术和翻修手术,如切除溃疡并重新进行胃空肠吻合术、切除溃疡和胃袋并进行食管空肠吻合术,或切除溃疡并翻修至正常解剖结构。手术干预需要专业技术,应在合格、高产量的中心进行。为了帮助临床医生理解 MU 的细微差别,我们进行了文献综述,并对研究结果进行了总结。此外,我们还提出了一种算法,划分了从内科治疗到内窥镜治疗再到外科治疗的MU治疗升级过程。这篇简明扼要的综述旨在帮助临床医生预防和治疗边缘溃疡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信